These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 3299928)

  • 1. Immunological competence and host-specific tolerance of antibody-facilitated bone marrow chimeras.
    McCarthy SA; Griffith IJ; Gambel P; Francescutti LH; Fotedar A; Diener E; Wegmann TG
    Transplantation; 1987 Jul; 44(1):97-105. PubMed ID: 3299928
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterization of host lymphoid cells in antibody-facilitated bone marrow chimeras.
    McCarthy SA; Griffith IJ; Gambel P; Francescutti LH; Wegmann TG
    Transplantation; 1985 Jul; 40(1):12-7. PubMed ID: 3892791
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Leucyl-leucine methyl ester treatment of donor cells permits establishment of immunocompetent parent----F1 chimeras that are selectively tolerant of host alloantigens.
    Thiele DL; Calomeni JA; Lipsky PE
    J Immunol; 1987 Oct; 139(7):2137-42. PubMed ID: 3309052
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ia-restricted B-B cell interaction. I. The MHC haplotype of bone marrow cells present during B cell ontogeny dictates the self-recognition specificity of B cells in the polyclonal B cell activation by a B cell differentiation factor, B151-TRF2.
    Ono S; Takahama Y; Hamaoka T
    J Immunol; 1987 Nov; 139(10):3213-23. PubMed ID: 3316381
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tolerance, immunocompetence, and secondary disease in fully allogeneic radiation chimeras.
    Rayfield LS; Brent L
    Transplantation; 1983 Aug; 36(2):183-9. PubMed ID: 6349042
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term immunologic tolerance induction in chimeric mice after bone marrow transplantation across major histocompatibility barriers: persistent or redeveloping immunologic responsiveness after prolonged survival.
    Sugiura K; Yasumizu R; Iwai H; Inaba MM; Toki J; Ogura M; Hara I; Good RA; Ikehara S
    Thymus; 1991 Nov; 18(3):137-53. PubMed ID: 1838450
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Graft-facilitating doses of ex vivo activated gammadelta T cells do not cause lethal murine graft-vs.-host disease.
    Drobyski WR; Majewski D; Hanson G
    Biol Blood Marrow Transplant; 1999; 5(4):222-30. PubMed ID: 10465102
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Specific tolerance and immunocompetence in haploidentical, but not in completely allogeneic, canine chimeras treated with methotrexate and cyclosporine.
    Deeg HJ; Severns E; Raff RF; Sale GE; Storb R
    Transplantation; 1987 Nov; 44(5):621-32. PubMed ID: 2961110
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cellular mechanisms of alloimmune non-responsiveness in tolerant mixed lymphocyte chimeras induced by vascularized bone marrow transplants.
    Llull R; Ramsamooj R; Black KS; Hewitt CW
    Transpl Int; 1994; 7 Suppl 1():S453-6. PubMed ID: 11271279
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Assessment of immunocompetence by limiting dilution analysis in long-term T cell depletion chimeras transplanted across the MHC barrier.
    Vallera DA; Soderling CC; Orosz CG
    Transplantation; 1985 Sep; 40(3):311-6. PubMed ID: 2930921
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Alloantigen persistence in induction and maintenance of transplantation tolerance.
    Morecki S; Leshem B; Eid A; Slavin S
    J Exp Med; 1987 Jun; 165(6):1468-80. PubMed ID: 3295107
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Studies of immunologic tolerance to host minor histocompatibility antigens following allogeneic bone marrow transplantation in mice.
    Perreault C; Allard A; Brochu S; Poupart C; Fontaine P; Bélanger R; Gyger M
    Bone Marrow Transplant; 1990 Aug; 6(2):127-35. PubMed ID: 2145050
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Host-reactive cytotoxic T lymphocyte precursors in long-lived fully allogeneic mouse bone marrow chimeras.
    Heeg K; Reimann J; Heit H; Heit W; Wagner H
    Scand J Immunol; 1986 Feb; 23(2):201-9. PubMed ID: 3485304
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tolerance of CD8+ T cells developing in parent-->F1 chimeras prepared with supralethal irradiation: step-wise induction of tolerance in the intrathymic and extrathymic environments.
    Kosaka H; Sprent J
    J Exp Med; 1993 Feb; 177(2):367-78. PubMed ID: 8426108
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Monoclonal antibodies for the prevention of graft-versus-host disease and marrow graft rejection. The depletion of T cell subsets in vitro and in vivo.
    Cobbold S; Martin G; Waldmann H
    Transplantation; 1986 Sep; 42(3):239-47. PubMed ID: 3529524
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Functional clonal deletion versus suppressor cell-induced transplantation tolerance in chimeras prepared with a short course of total-lymphoid irradiation.
    Slavin S; Morecki S; Weigensberg M; Bar S; Weiss L
    Transplantation; 1986 Jun; 41(6):680-7. PubMed ID: 2940736
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Influence of the additional injection of host-type bone marrow on the immune tolerance of minor antigen-mismatched chimeras: possible involvement of double-negative (natural killer) T cells.
    Sefrioui H; Billiau AD; Overbergh L; Rutgeerts O; Waer M
    Transplantation; 1999 Nov; 68(10):1560-7. PubMed ID: 10589955
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regulation of the immune response in experimental models of autoimmune disorders: I. Immunocompetence and transplantation tolerance in female (NZB X NZW)F1 hybrid mice immunosuppressed with total lymphoid irradiation and in reconstituted bone marrow chimeras.
    Moscovitch M; Slavin S
    J Clin Lab Immunol; 1983 Apr; 10(4):185-91. PubMed ID: 6345783
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Strong T cell tolerance in parent----F1 bone marrow chimeras prepared with supralethal irradiation. Evidence for clonal deletion and anergy.
    Gao EK; Lo D; Sprent J
    J Exp Med; 1990 Apr; 171(4):1101-21. PubMed ID: 2139098
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reconstitution of lymphoid tissues under the influence of a subclinical level of graft versus host reaction induced by bone marrow T cells or splenic T cell subsets.
    Hirano M; Arase H; Arase-Fukushi N; Ogasawara K; Iwabuchi K; Miyazaki T; Good RA; Onoé K
    Cell Immunol; 1993 Oct; 151(1):118-32. PubMed ID: 8402923
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.